Literature DB >> 19106538

[A case of synchronous triple cancer involving advanced hepatocellular carcinoma].

Junji Kawada1, Shogo Kobayashi, Hiroaki Nagano, Yoshiyuki Fujiwara, Masataka Ikeda, Shigeru Marubashi, Yutaka Takeda, Hisanori Hatano, Masahiro Tanemura, Toru Kitagawa, Keizo Dono, Koji Umeshita, Morito Monden, Masaki Mori, Yuichiro Doki.   

Abstract

We report herein a case of advanced hepatocellular carcinoma (HCC) with gastric cancer and rectal cancer. A 68-year-old man was diagnosed with advanced HCC and gastric cancer. At first, he was planned to be treated by trans-catheter arterial chemoembolization (TACE). After TACE, he was diagnosed with rectal cancer by following abdominal computed tomography (CT) and colonoscopy. Then, he was diagnosed with synchronous triple cancer. To avoid bleeding and obstruction, a resection of rectal cancer was performed secondly. After the surgery, he was treated by TACE for three times. HCC was well-controlled, but there remained a small active HCC lesion. Gastric cancer had little progressed, but was still resectable. Finally, we performed a partial hepatectomy and a distal gastrectomy simultaneously. Both of cancer stage and progression-related multimodal treatment is necessary in synchronous cancer.

Entities:  

Mesh:

Year:  2008        PMID: 19106538

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  2 in total

Review 1.  Small hepatocellular carcinoma suppressed by chemotherapy for synchronous gastric carcinoma after laparoscopy-assisted radical distal gastrectomy: A case report and literature review.

Authors:  Chao Wang; Xin Luo; Shui-Lin Dong; Chao Leng; Bi-Xiang Zhang; Bin-Hao Zhang
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

2.  Synchronous Hepatic Epithelioid Hemangioendothelioma and Hepatocellular Carcinoma: First Case Report in the Literature and Challenges.

Authors:  Panagiotis G Athanasopoulos; Christopher Hadjittofi; Tu Vinh Luong; James O'Beirne; Dinesh Sharma
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.